Maynard Um
-
-
-
-
-
-
-
Cardiol Therapeutics CEO to discuss trial results in live interview
-
-
-
-
-
-
-
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Cardiol Therapeutics (CRDL)
-
-
-
-
-
-
-
Cardiol Therapeutics raises $11 million, extends cash runway to Q3 2027
-
-
-
-
-
-
-
Cardiol Therapeutics Announces Database Lock for Phase II ARCHER Trial of CardiolRx(TM) in Acute Myocarditis
-
-
-
-
-
-
-
Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
-
-
-
-
-
-
-
Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
448,566 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

